Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CarMax, Inc (KMX) vs Summit Therapeutics Inc (SMMT) Price & Performance

CarMax, IncTrade
Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

CarMax, Inc vs Summit Therapeutics Inc — how do they compare? CarMax, Inc trades at $59.96 (market cap $8.33B), while Summit Therapeutics Inc trades at $14.02 (market cap $12.06B). The key difference: Summit Therapeutics Inc is the larger of the two by market cap, and CarMax, Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

KMXSMMT
Market Cap
$8.33B$12.06B
Sector
Consumer CyclicalHealth
52-Week High
$62.17$26.98
52-Week Low
$30.88$12.55
Enterprise Value
$26.84B$11.39B

Returns comparison

Trailing returns across standard periods

About CarMax, Inc

CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.

Read more on KMX

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT